AMDUCA states that it may prohibit an extra-label drug use in animals if it found that such use presents a risk to public health.

AMDUCA states that it may prohibit an extra-label drug use in animals if it found that such use presents a risk to public health.

• A. True
• B. False
• C. Not specified
• D. Only for human drugs

Answer: (A)

The main idea is that AMDUCA sets up a control point to protect public health while allowing veterinarians to use drugs extra-label under specific safeguards. Under AMDUCA, extra-label drug use is allowed only with strict conditions, but if evidence shows that the use would pose a risk to public health—such as unsafe drug residues in edible animal products or other safety concerns—the FDA can prohibit that particular extra-label use. So the statement is true: AMDUCA may prohibit an extra-label drug use in animals if it finds that such use presents a risk to public health. The law is not limited to human drugs, and it isn’t an absolute prohibition—it balances therapeutic flexibility with public-health protection.

The main idea is that AMDUCA sets up a control point to protect public health while allowing veterinarians to use drugs extra-label under specific safeguards. Under AMDUCA, extra-label drug use is allowed only with strict conditions, but if evidence shows that the use would pose a risk to public health—such as unsafe drug residues in edible animal products or other safety concerns—the FDA can prohibit that particular extra-label use. So the statement is true: AMDUCA may prohibit an extra-label drug use in animals if it finds that such use presents a risk to public health. The law is not limited to human drugs, and it isn’t an absolute prohibition—it balances therapeutic flexibility with public-health protection.